Skip to main content
. 2023 Feb 2;14:1125576. doi: 10.3389/fphar.2023.1125576

FIGURE 1.

FIGURE 1

Flowchart of study population. AF: atrial fibrillation; CKD: chronic kidney disease; DVT: deep vein thrombosis; IMA: InterMutualistic Agency; NOAC: non-vitamin K antagonist oral anticoagulant; OAC: oral anticoagulant; PE: pulmonary embolism; VKA: vitamin K antagonist.